Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320983 · ClinicalTrials.gov registry record · Phase 1
Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
A Phase 1 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT00320983 is a Phase 1 study that has completed, run by University of New Mexico. The registered enrollment target is 11 participants.
The verdict
NCT00320983, a Phase 1 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
A Phase I Study of Adjuvant Topotecan and Cisplatin with Concurrent Radiation Therapy for Advanced Cervical Cancer.
Interventions
- DRUG Cisplatin
- DRUG Topotecan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2002-03 |
| Est. Completion | 2005-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320983
The ClinicalTrials.gov registry entry for NCT00320983 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cisplatin is the first listed.
NCT00320983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320983 about?
NCT00320983 is a clinical study titled "Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer". A Phase I Study of Adjuvant Topotecan and Cisplatin with Concurrent Radiation Therapy for Advanced Cervical Cancer.
What is the current status of trial NCT00320983?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2002-03. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00320983?
The interventions under investigation include: Cisplatin (DRUG), Topotecan (DRUG).
Who is sponsoring clinical trial NCT00320983?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.